Benzodiazepines are commonly prescribed drugs with approximately 10% of adults having used them in the past year. These drugs are clearly addictive, yet many patients are prescribed these for years, with longterm side effects. The present study aimed to investigate whether patients on repeat diazepam prescription had their prescription reviewed to reduce and to stop the repeat prescription wherever appropriate, and whether these changes were sustained at 24 months. Methods: The present study used a minimal intervention strategy to reduce diazepam use in a semi-rural general practice. Patients with a current prescription for diazepam were invited to visit their general practitioner for a review. Dose reduction grids were formulated for each individual to facilitate a downward titration by 1 mg each wk/ mo. Patients with psychiatric co-morbidity were also included. Interrupted time series methods were applied to the monthly data. The outcomes were evaluated at 12 and 24 months. Results: Ninety-two patients had diazepam on repeat prescription with 87 (94.6%) attending the review appointment. Twenty-seven patients (29.3%) were under psychiatric review and were supported by the psychiatrist with a downward titration regime. At 24 months, 63 patients (81.8% of the 77 still at the practice) had stopped or were in the process of stopping regular use of diazepam. A statistically significant reduction in total monthly diazepam prescription was observed (from 2.2 to 0.7 defined daily dose/1,000 patients/d). Conclusion: This minimal intervention strategy, in collaboration between primary and secondary care, produced a durable reduction in overall diazepam prescription at the general practice.
INTRODUCTION
Benzodiazepines, and particularly diazepam, are commonly prescribed drugs. A recent study has found that almost 10% of the adults had taken a benzodiazepine in the past year. 1) Benzodiazepines are used for the treatment of epilepsy, severe muscle spasm, and as premedicants. However, majority of the prescriptions are for their hypnotic and anxiolytic effects. They may also be used as adjuncts in the treatment of depression and schizophrenia, 1) albeit with scarce evidence. 2, 3) Although useful in the management of generalized anxiety disorder (GAD), 4, 5) perhaps less so in comparison to alternatives when used as hypnotics, 6, 7) these drugs are clearly addictive. Many patients continue to take them for years with unknown benefits and likely harms. 8) NICE (The National Institute for Health and Care Excellence) recommends the use of benzodiazepines as a short-term measure during crisis in GAD, and not routinely for longer than a month. 2) Repeat prescriptions should be avoided in patients with major personality disorders or a history of substance misuse. In the latter group, benzodiazepines are often misused alongside other substances, 9, 10) and are commonly implicated in drug related deaths.
11)
Long-term side effects of chronic benzodiazepine use are well documented. These include increased risk of falls and associated sequelae, 12) anterograde amnesia, 13) and adverse effects on driving performance. 14) Withdrawal symptoms can occur after 4-6 weeks, and at least a third of long-term users experience problems on dosage reduction or withdrawal. 15) The decision to prescribe benzodiazepines is complex and multifactorial with particular individual variation. 16) Unfortunately, given the reduced continuity of care within general practice, unmonitored and repeat benzodiazepine prescriptions are common. Long-term side effects are of particular concern among older adults. 12, 13) In the United Kingdom, the majority of prescriptions in general practice are written by medical doctors, with some practices employ- trainees. It has seen a 60% increase in the number of diazepam prescriptions given to patients over the past 4 years after correction for practice population numbers. The defined daily dose (DDD) per 1,000
patients on the practice list per day increased from 1.60 to 2.52 during this period. This rise is associated with a wide variation in prescribing habits between individual GPs, and has prompted further investigation.
Minimal intervention strategies have been demonstrated to increase the odds of a patient stopping their benzodiazepine by threefold. [17] [18] [19] [20] These odds are further doubled by creation of systematic reduction strategies. 17, 19) This evidence was the basis for our methodology.
We had the following questions before the study. 
METHODS

Study Design
Formal planning for the study took place from October 2014, including identification of patients, with the full intervention taking place between January 2015 and January 2017. All the patients with "current"
repeat prescription of diazepam (receiving it at regular intervals with/ without other long-term therapies) were identified on "Vision" (primary care IT system with electronic patient record and prescribing).
The individual files were examined for indication, dose, treatment duration, and review details.
Patients were sent a specific review appointment letter according to the appointment capacity. This letter advised the patients about the importance of attending the review appointment to allow appropriate diazepam prescribing, to receive support, and to discuss any difficulties with their GP. Tapering regimes were formulated by the pharmacist prescriber or the medication technician based on current best practice. 17, 21) Dose reduction grids for each patient facilitated a downward titration of 1 mg each wk/mo depending upon the individual circumstances.
The pharmacy team determined the exact quantities and doses of tablets for the patient while liaising with the local dispensaries. All the prescriptions were dispensed weekly, based on current recommendations.
22)
Selection of Study Subjects
No exclusion criteria were applied while selecting the subjects. Problematic benzodiazepine withdrawal is expected in patients with a history of substance misuse and in those with a co-morbid severe physical/psychiatric disorder or personality disorder. 15, 23) Complex patients were titrated down, where appropriate, by their psychiatrist after liaising with their GP, and were included in the results.
Measurements and Outcomes
Outcomes for deceased individuals or those who had moved practice were noted as a part of an attrition analysis. Evaluation was carried out at 12 months and 24 months from the beginning of the study to allow assessment of the initial effect of the intervention and relapse-prevention.
Monthly aggregated data from January 2012 to February 2017 were extracted from the PIS (Prescribing Information System) using the PRISMS (Prescribing Information System for Scotland) database
Statistical Analysis
Pre-intervention characteristics of patients with diazepam on repeat prescription within the last 6 months were described using counts and percentages. Given the temporal nature of the monthly rates of pre- 
Ethical Approval
This study was considered a local service evaluation or a quality im- 
RESULTS
Pre-intervention
Ninety-two patients had a repeat prescription for diazepam. Sixty-one percent were male. Age of the patients ranged from 28 to 83 years. The average time on diazepam was 81 months (range, 2 months to 23 years). Forty-five percent of the patients had been on diazepam for more than 5 years. The total daily dose was between 2 mg and 25 mg.
Fifty-seven (62%) of the repeat prescriptions of diazepam were initially prescribed for a psychiatric indication. Fifty-two patients (56.5%) had undergone a medication review past 4 months.
Initially, 27 patients (29.3%) were under psychiatric evaluation.
Their diazepam dose was reviewed and reduced, if appropriate, by their psychiatrist. Eight patients (8.7%) were occasionally using extremely low doses of diazepam and were given a suitable titration plan.
Fifty-seven patients (62.0%) were eligible for the standard intervention (Table 1) .
Post-intervention
Initial follow-up took place 12 months after the intervention. Attendance was very high, with 87 patients (94.6%) attending the review appointment to discuss the intervention. At 12 months, 51 patients (55.4%) had successfully titrated down and stopped diazepam ( Table   2 ). Two patients were continued on a slower titration plan, 11 (12.0%)
were using diazepam intermittently, and 28 (30.4%) were unable to stop using diazepam. Due to a boundary change, seven patients had moved GP practice. Eighty patients remained at the practice. Five patients had died. In total, 28 patients (30.4%) were unable to participate in a reducing regime. Following full implementation at month 37, the prescribing rate was around 2.0 DDD per 1,000 ppdpm with a shallower decline of 0.032 DDD per 1,000 ppdpm (95% CI, 0.021 to 0.043) to a rate of 1.3 DDD per 1,000 ppdpm by the end of the study. The monthly linear declines in diazepam and benzodiazepines prescribing rates were almost identical after full implementation at month 37.
DISCUSSION
Summary
At 24 months, the vast majority of patients who were previously on re- Values are presented as number (%) or number. 
Strengths and Limitations
The success of this intervention can be attributed to many factors, all involving multidisciplinary teamwork including the planning of appointments, advance preparation of individual diazepam dosing charts and prescriptions, documentation of stages in the notes, and monitoring of patient attendance. The project depended on shared understanding from the GPs and the pharmacy team.
Individual circumstances were considered before agreeing on downward titration plans. We achieved good concordance and patients were strongly encouraged to stay on plan, rather than reduce the dose more rapidly than the recommended regimen. Patients on longstanding diazepam prescriptions were given a monthly dose reduction and those on shorter term or smaller doses, a weekly dose reduction. It was considered important that patients were scheduled with their usual GP.
An effective working relationship with the local psychiatrist, for advice and discussion, was advantageous for more complex patients.
This included weekly clinics to consult with patients, and a quarterly meeting with clinicians at the practice to discuss patients' progress.
The psychiatrist established and concurred the plans with their patients who were able to reduce their diazepam.
The present study had some limitations. A gold standard follow-up investigation could have included repeat urine drug screens on completion of the titration regime. This would have confirmed that patients were not sourcing diazepam from alternative means. This was difficult to justify in a group that was using diazepam regularly but was not likely to meet diagnostic criteria for benzodiazepine dependence. 25) Diazepam was the only benzodiazepine examined separately. A similar study of other commonly prescribed benzodiazepines could have been conducted. However, it would have involved far fewer patients. Figure 1B demonstrates that there was no compensatory pattern of prescribing alternative benzodiazepines while diazepam prescribing had reduced.
Ten patients (10.9%) had moved to neighboring GP practices due to a newly enforced boundary change. The change in practice policy of prescribing diazepam was not a factor for patients moving to other practices as confirmed by our attrition analysis.
Comparison with Existing Literature
The findings in the present study are consistent with those of previous studies on the successful use of minimal intervention strategies in primary care. [17] [18] [19] [20] In contrast to similar studies, 19, 20) our coordination with the local psychiatrist allowed the investigation of the intervention on patients involved with psychiatry and substance misuse services.
There has been limited research into relapse prevention following such interventions with the exception of two studies. In comparison to the study by Voshaar et al., 26) the present study was more proactive by ensuring all the patients at the practice had an attempted reduction, rather than a patient-led opt-in with comparatively favorable results.
Vicens et al. 27) found that an intense follow-up regime was demonstrated similar efficacy to a structured intervention with written instructions, which supports the decision to use the latter approach in our study. Both the studies excluded psychiatric patients. There is growing evidence for encouraging approaches that modify GP attitudes towards prescribing benzodiazepines and utilizing nonpharmacological alternatives. 29, 30) Maintenance of positive prescribing practices and associated attitudes between GP partners has been streamlined through practice meetings and a practice protocol for the prescribing of diazepam. This information has been added to the practice's induction program and locum pack. This could be implemented in all similar teaching practices.
Implications for Research and/or Practice
Conclusion
To summarize, this study has been able to produce a statistically significant, durable reduction in overall diazepam prescribing by using a minimal intervention strategy and maintaining a collaborative, proactive relationship between primary and secondary care providers.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
passionate manner. The authors would like to recognize the role of Karen Box in collating the prescribing data. Finally, the authors would like to thank the patients involved in the study, with many having made a responsible, informed choice to reduce or stop their regular diazepam prescriptions when this medication was not absolutely necessary.
ORCID
